U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C16H13F2N5O2
Molecular Weight 345.3035
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]-3-nitropyrazolo[1,5-a]pyrimidine

SMILES

[O-][N+](=O)C1=C2N=C(C=CN2N=C1)N3CCC[C@@H]3C4=CC(F)=CC=C4F

InChI

InChIKey=ZVNXKHRULOZLHG-CYBMUJFWSA-N
InChI=1S/C16H13F2N5O2/c17-10-3-4-12(18)11(8-10)13-2-1-6-21(13)15-5-7-22-16(20-15)14(9-19-22)23(24)25/h3-5,7-9,13H,1-2,6H2/t13-/m1/s1

HIDE SMILES / InChI

Approval Year

Name Type Language
5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]-3-nitropyrazolo[1,5-a]pyrimidine
Systematic Name English
Larotrectinib DFP-PNPP Impurity
Preferred Name English
Pyrazolo[1,5-a]pyrimidine, 5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]-3-nitro-
Systematic Name English
Code System Code Type Description
CAS
1223404-90-7
Created by admin on Wed Apr 02 16:38:38 GMT 2025 , Edited by admin on Wed Apr 02 16:38:38 GMT 2025
PRIMARY
EPA CompTox
DTXSID301136532
Created by admin on Wed Apr 02 16:38:38 GMT 2025 , Edited by admin on Wed Apr 02 16:38:38 GMT 2025
PRIMARY
PUBCHEM
67329819
Created by admin on Wed Apr 02 16:38:38 GMT 2025 , Edited by admin on Wed Apr 02 16:38:38 GMT 2025
PRIMARY
FDA UNII
HK74TQK39R
Created by admin on Wed Apr 02 16:38:38 GMT 2025 , Edited by admin on Wed Apr 02 16:38:38 GMT 2025
PRIMARY